Excelsior Sciences

Company website description: Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing.

Tracked VC backers: 1

Visit excelsiorsci.com ↗Product description source ↗

Product source checked 31 Oct 2026

View in My Fund →

Publicly documented VC backing

These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.

Khosla Ventures

Listed as “Excelsior Sciences”

First observed:: 31 Oct 2026
Investment announced:: Date not recorded

View source ↗

Dated public activity

No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.